Canventol is an antitumor agent that inhibits the release of TNF-α . Canventol inhibits protein isoprenylation, regulates mevalonate metabolism, enhances Okadaic acid ( HY-N6785 )-induced early response gene expression, suppresses cell transformation, and inhibits HIV-1 production in infected cells. Canventol can be used in studies related to skin tumor promotion and cancer .
Products | Products > Disease Areas > Sexually Transmitted Disease | Products > Disease Areas > HIV-1 Infection | Products > Disease Areas > Infection | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Cancer | Products > Disease Areas > HIV Infection | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > HIV
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.